LRP1 and carcinoma: In LRP-1-silenced cells, inhibition of JNK signaling by SP600125 (Fig. 8G vs 8F) or overexpression of kinase-inactive JNK-1 (Fig. 8J vs 8H) restored the mesenchymal-like morphology of wild-type carcinoma cells.